Task preparation as a mnemonic: The benefits of drawing (and not drawing).

Psychon Bull Rev

Department of Psychology, University of Waterloo, Waterloo, Ontario, Canada.

Published: December 2018

Creating a visual representation of an item through drawing affords that item a substantive memory benefit, relative to several control tasks. Recent findings demonstrate the robustness of this drawing effect across several stimulus classes, irrespective of encoding time, setting, age group, or memory measure. The advantage for drawn information has been attributed to the integrated contributions of at least three components of visual production through drawing, which can independently facilitate memory: elaborative, motoric, and pictorial. In the current work, we investigated the importance of the elaborative process one must engage in while preparing to draw, and directly tested whether this generative period alone was sufficient to improve memory. Participants were prompted to either draw or write out presented words, and were provided with a 1- or 2-s preparatory period prior to completing the prompted task. Critically, on a subset of the trials, participants were prevented from completing the prompted task. There was strong evidence in support of better memory for drawn items, which replicates the drawing effect commonly observed in prior work. Interestingly, following prompts to draw, there was also a reliable memory benefit of the preparatory period alone. In other words, simply engaging in the elaborative process of preparing to draw (i.e., without completing the drawing) was enough to produce a reliable increase in later memory relative to actually writing.

Download full-text PDF

Source
http://dx.doi.org/10.3758/s13423-018-1477-yDOI Listing

Publication Analysis

Top Keywords

memory benefit
8
elaborative process
8
preparing draw
8
preparatory period
8
completing prompted
8
prompted task
8
drawing
7
memory
7
task preparation
4
preparation mnemonic
4

Similar Publications

Role of Trained Immunity in Heath and Disease.

Curr Cardiol Rep

January 2025

Center for Cardiovascular Research, Division of Cardiology, Department of Medicine, Washington University School of Medicine, 660 S Euclid Ave, Campus Box 8086, St. Louis, MO, 63110, USA.

Purpose Of Review: This review aims to explore the role of immune memory and trained immunity, focusing on how innate immune cells like monocytes, macrophages, and natural killer cells undergo long-term epigenetic and metabolic rewiring. Specifically, it examines the mechanisms by which trained immunity, often triggered by infection or vaccination, could impact cardiac processes and contribute to both protective and pathological responses within the cardiovascular system.

Recent Findings: Recent research demonstrates that vaccination and infection not only activate immune responses in circulating monocytes and tissue macrophages but also affect immune progenitor cells within the bone marrow environment, conferring lasting protection against heterologous infections.

View Article and Find Full Text PDF

Reports an error in "A grain of truth in the grain size effect: Retrieval practice is more effective when interspersed during learning" by Hilary J. Don, Shaun Boustani, Chunliang Yang and David R. Shanks (, 2024[Nov], Vol 50[11], 1791-1810).

View Article and Find Full Text PDF

Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated cancer, and immune checkpoint inhibitors (ICIs) have shown efficacy in its treatment. The combination of chemotherapy and ICIs represents a new trend in the standard care for metastatic NPC. In this study, we aim to clarify the immune cell profile and related prognostic factors in the ICI-based treatment of metastatic NPC.

View Article and Find Full Text PDF

Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease.

J Prev Alzheimers Dis

January 2025

Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, BioClinicum, 171 64 Solna, Sweden; Theme Inflammation and Aging, Karolinska University Hospital, 141 86 Stockholm, Sweden.

The advancement of disease-modifying treatments (DMTs) for Alzheimer's disease (AD), along with the approval of three amyloid-targeting therapies in the US and several other countries, represents a significant development in the treatment landscape, offering new hope for addressing this once untreatable chronic progressive disease. However, significant challenges persist that could impede the successful integration of this class of drugs into clinical practice. These challenges include determining patient eligibility, appropriate use of diagnostic tools and genetic testing in patient care pathways, effective detection and monitoring of side effects, and improving the healthcare system's readiness by engaging both primary care and dementia specialists.

View Article and Find Full Text PDF

Background: There are no approved oral disease-modifying treatments for Alzheimer's disease (AD).

Objectives: The objective of this study was to assess efficacy and safety of blarcamesine (ANAVEX®2-73), an orally available small-molecule activator of the sigma-1 receptor (SIGMAR1) in early AD through restoration of cellular homeostasis including autophagy enhancement.

Design: ANAVEX2-73-AD-004 was a randomized, double-blind, placebo-controlled, 48-week Phase IIb/III trial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!